Well that explains it! What’s your take on results this coming week ? Good or great? And what do you expect for S2C? What about RLFTF inhaled drug? A shelf offering scares me on that one, I can’t find out if there’s one lurking or not. The company is not on Edgar/SEC filings. Thanks